Highly Profitable Orphans Can Have Exclusivity Reduced Under EC Proposal
Executive Summary
Orphan drugs marketed in the European Union that are found to be making an "unreasonable profit" may face a reduction of market exclusivity time, according to the European Commission's proposal for an orphan products regulation.